Balyasny Asset Management
CDNA icon

Balyasny Asset Management’s CareDx CDNA Stock Holding History

Balyasny Asset Management’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-99,870
Closed -$1.88M – 2941
2025
Q4 		$1.88M Buy
99,870
+59,748
+149% +$1M ﹤0.01% 1897
2025
Q3 		$583K Sell
40,122
-1,919
-5% -$27.4K ﹤0.01% 2330
2025
Q2 		$821K Buy
+42,041
New +$747K ﹤0.01% 2112
2024
Q3 		– Sell
-48,423
Closed -$752K – 2773
2024
Q2 		$752K Buy
+48,423
New +$585K ﹤0.01% 1900
2023
Q4 		– Sell
-17,038
Closed -$119K – 2524
2023
Q3 		$119K Buy
+17,038
New +$157K ﹤0.01% 2106
2023
Q1 		– Sell
-1,267
Closed -$14.5K – 2697
2022
Q4 		$14.5K Sell
1,267
-34,720
-96% -$515K ﹤0.01% 2523
2022
Q3 		$612K Buy
+35,987
New +$772K ﹤0.01% 1977
2022
Q1 		– Sell
-287,029
Closed -$13.1M – 2503
2021
Q4 		$13.1M Buy
287,029
+24,582
+9% +$1.28M 0.04% 554
2021
Q3 		$16.6M Buy
262,447
+11,093
+4% +$845K 0.07% 392
2021
Q2 		$23M Sell
251,354
-132,610
-35% -$10.5M 0.11% 255
2021
Q1 		$26.1M Buy
383,964
+148,999
+63% +$11.6M 0.13% 201
2020
Q4 		$17M Sell
234,965
-134,846
-36% -$7.81M 0.09% 300
2020
Q3 		$14M Buy
369,811
+278,290
+304% +$9.4M 0.1% 286
2020
Q2 		$3.24M Sell
91,521
-143,191
-61% -$4.08M 0.03% 617
2020
Q1 		$5.12M Sell
234,712
-156,627
-40% -$3.51M 0.06% 397
2019
Q4 		$8.44M Buy
+391,339
New +$8.98M 0.05% 474
2019
Q2 		– Sell
-9,935
Closed -$313K – 1493
2019
Q1 		$313K Buy
+9,935
New +$289K ﹤0.01% 1294

Other funds holding CDNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return

Balyasny Asset Management's CDNA Position: Q1 2026 in Review

Balyasny Asset Management sold out of CareDx (CDNA) in Q1 2026, closing a stake of 99,870 shares — an estimated $1.88M sold.

Balyasny Asset Management first reported a position in CDNA in Q1 2019 and held it in 17 quarters. The position peaked at $26.1M in Q1 2021. 191 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.

  • Balyasny Asset Management reported no remaining CareDx position as of Q1 2026 after selling out during the quarter.
  • Balyasny Asset Management sold 99,870 CareDx shares in Q1 2026, an estimated $1.88M.
  • Balyasny Asset Management first reported a position in CareDx in Q1 2019 and held it in 17 quarters.
  • Balyasny Asset Management's CareDx position peaked at $26.1M in Q1 2021.
  • 191 funds tracked by Wall St. Rank held CareDx as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.